Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
INTREXON CORP
Jurisdiction of Incorporation/Organization
VI
Year of Incorporation/Organization
Over Five Years Ago
Previous Name(s)
- GENOMATIX CORPORATION
- GENOMATIX, INC.
Item 2 Issuer Principal Place of Business and Contact Information
1750 KRAFT DRIVE
SUITE 1400
BLACKSBURG, VA 24060
Phone Number:
subscription required
Item 3. Related Persons
Name
THOMAS REED
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
SUNIL CHADA
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
RICK STERLING
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
ROBERT P. BEECH
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
RANDAL J. KIRK
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
CESAR L. ALVAREZ
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
STEVEN FRANK
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
LARRY HORNER
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
DEAN J. MITCHELL
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
BURTON SOBEL
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
RONALD B. HERBERMAN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
GRACE COLON
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
TOM GORALSKI
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
GERARDO ZAPATA
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MATT CRISP
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
BIOTECHNOLOGY
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
01/26/2011
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
Yes
Item 9. Type(s) of Securities Offered
- Equity
- Option, Warrant or Other Right to Acquire Another Security
- Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
- Other: EACH WARRANT IS EXERCISABLE FOR ONE COMMON SHARE AT AN EXERCISE PRICE OF $0.4498574 PER SHARE UNTIL DECEMBER 13, 2017.
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
Yes
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 13. Offering and Sales Amounts
Total Offering Amount
1346625
Total Amount Sold
1013625
Total Remaining to be Sold
333000
Clarification of Response
THE ADDITIONAL $333,000 MAY BE RECEIVED UPON EXERCISE OF SHARE PURCHASE WARRANTS.
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
3
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
INTREXON CORP
Issuer Signature
/S/ RICK STERLING
Signer Name
RICK STERLING
Signer Title
CHIEF FINANCIAL OFFICER
Signature Date
02/09/2011